{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:24:16Z","timestamp":1773980656303,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T00:00:00Z","timestamp":1400284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00428-014-1584-8","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T08:55:07Z","timestamp":1400230507000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma"],"prefix":"10.1007","volume":"465","author":[{"given":"Lisa","family":"Arzt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannelore","family":"Kothmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Halbwedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut H.","family":"Popper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,17]]},"reference":[{"issue":"3","key":"1584_CR1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.seminoncol.2005.02.010","volume":"32","author":"NJ Vogelzang","year":"2005","unstructured":"Vogelzang NJ, Porta C, Mutti L (2005) New agents in the management of advanced mesothelioma. Semin Oncol 32(3):336\u2013350","journal-title":"Semin Oncol"},{"issue":"5","key":"1584_CR2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2353\/ajpath.2009.090400","volume":"175","author":"A Shukla","year":"2009","unstructured":"Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR, Mossman BT (2009) Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. Am J Pathol 175(5):2197\u20132206. doi: 10.2353\/ajpath.2009.090400","journal-title":"Am J Pathol"},{"issue":"4","key":"1584_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jcb.20828","volume":"98","author":"ME Ramos-Nino","year":"2006","unstructured":"Ramos-Nino ME, Testa JR, Altomare DA, Pass HI, Carbone M, Bocchetta M, Mossman BT (2006) Cellular and molecular parameters of mesothelioma. J Cell Biochem 98(4):723\u2013734. doi: 10.1002\/jcb.20828","journal-title":"J Cell Biochem"},{"issue":"1","key":"1584_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/sonc.2002.30234","volume":"29","author":"AK Nowak","year":"2002","unstructured":"Nowak AK, Lake RA, Kindler HL, Robinson BW (2002) New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol 29(1):82\u201396","journal-title":"Semin Oncol"},{"issue":"9","key":"1584_CR5","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/1097-0142(19941101)74:9<2460::AID-CNCR2820740912>3.0.CO;2-N","volume":"74","author":"C Boutin","year":"1994","unstructured":"Boutin C, Nussbaum E, Monnet I, Bignon J, Vanderschueren R, Guerin JC, Menard O, Mignot P, Dabouis G, Douillard JY (1994) Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 74(9):2460\u20132467","journal-title":"Cancer"},{"issue":"1","key":"1584_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00001813-199502000-00009","volume":"6","author":"A Hand","year":"1995","unstructured":"Hand A, Pelin K, Mattson K, Linnainmaa K (1995) Interferon (IFN)-alpha and IFN-gamma in combination with methotrexate: in vitro sensitivity studies in four human mesothelioma cell lines. Anticancer Drugs 6(1):77\u201382","journal-title":"Anticancer Drugs"},{"issue":"6","key":"1584_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00001813-199212000-00020","volume":"3","author":"AM Hand","year":"1992","unstructured":"Hand AM, Husgafvel-Pursiainen K, Pelin K, Vallas M, Suitiala T, Ekman A, Mattson M, Mattson K, Linnainmaa K (1992) Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines. Anticancer Drugs 3(6):687\u2013694","journal-title":"Anticancer Drugs"},{"issue":"3","key":"1584_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3835(91)90102-N","volume":"58","author":"AM Hand","year":"1991","unstructured":"Hand AM, Husgafvel-Pursiainen K, Tammilehto L, Mattson K, Linnainmaa K (1991) Malignant mesothelioma: the antiproliferative effect of cytokine combinations on three human mesothelioma cell lines. Cancer Lett 58(3):205\u2013210","journal-title":"Cancer Lett"},{"issue":"2","key":"1584_CR9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1165\/ajrcmb.16.2.9032125","volume":"16","author":"L Phan-Bich","year":"1997","unstructured":"Phan-Bich L, Buard A, Petit JF, Zeng L, Tenu JP, Chretien P, Monnet I, Boutin C, Bignon J, Lemaire G, Jaurand MC (1997) Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gamma. Am J Respir Cell Mol Biol 16(2):178\u2013186. doi: 10.1165\/ajrcmb.16.2.9032125","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"1584_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ijc.2910550331","volume":"55","author":"L Zeng","year":"1993","unstructured":"Zeng L, Buard A, Monnet I, Boutin C, Fleury J, Saint-Etienne L, Brochard P, Bignon J, Jaurand MC (1993) In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines. Int J Cancer 55(3):515\u2013520","journal-title":"Int J Cancer"},{"issue":"4","key":"1584_CR11","first-page":"840","volume":"58","author":"A Buard","year":"1998","unstructured":"Buard A, Vivo C, Monnet I, Boutin C, Pilatte Y, Jaurand MC (1998) Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma. Cancer Res 58(4):840\u2013847","journal-title":"Cancer Res"},{"issue":"Pt 8","key":"1584_CR12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA (2004) The JAK\/STAT signaling pathway. J Cell Sci 117(Pt 8):1281\u20131283. doi: 10.1242\/jcs.00963","journal-title":"J Cell Sci"},{"issue":"2","key":"1584_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.10364","volume":"197","author":"V Calo","year":"2003","unstructured":"Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 197(2):157\u2013168. doi: 10.1002\/jcp.10364","journal-title":"J Cell Physiol"},{"issue":"8","key":"1584_CR14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nri1885","volume":"6","author":"NC Reich","year":"2006","unstructured":"Reich NC, Liu L (2006) Tracking STAT nuclear traffic. Nat Rev Immunol 6(8):602\u2013612. doi: 10.1038\/nri1885","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"1584_CR15","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1073\/pnas.0801794105","volume":"105","author":"I Sadzak","year":"2008","unstructured":"Sadzak I, Schiff M, Gattermeier I, Glinitzer R, Sauer I, Saalmuller A, Yang E, Schaljo B, Kovarik P (2008) Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain. Proc Natl Acad Sci USA 105(26):8944\u20138949. doi: 10.1073\/pnas.0801794105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1584_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08977190500178745","volume":"23","author":"A Stephanou","year":"2005","unstructured":"Stephanou A, Latchman DS (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23(3):177\u2013182. doi: 10.1080\/08977190500178745","journal-title":"Growth Factors"},{"issue":"4","key":"1584_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/thx.2007.085241","volume":"63","author":"H Kothmaier","year":"2008","unstructured":"Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE, Murer B, Cagle PT, Attanoos R, Gibbs AR, Galateau-Salle F, Popper HH (2008) EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors. Thorax 63(4):345\u2013351. doi: 10.1136\/thx.2007.085241","journal-title":"Thorax"},{"issue":"4","key":"1584_CR18","first-page":"945","volume":"8","author":"R Buettner","year":"2002","unstructured":"Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8(4):945\u2013954","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1584_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","volume":"279","author":"S Wormald","year":"2004","unstructured":"Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279(2):821\u2013824. doi: 10.1074\/jbc.R300030200","journal-title":"J Biol Chem"},{"issue":"10","key":"1584_CR20","first-page":"845","volume":"92","author":"L Espert","year":"2005","unstructured":"Espert L, Dusanter-Fourt I, Chelbi-Alix MK (2005) Negative regulation of the JAK\/STAT: pathway implication in tumorigenesis. Bull Cancer 92(10):845\u2013857","journal-title":"Bull Cancer"},{"key":"1584_CR21","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.2741\/2893","volume":"13","author":"L Klampfer","year":"2008","unstructured":"Klampfer L (2008) The role of signal transducers and activators of transcription in colon cancer. Front Biosci 13:2888\u20132899","journal-title":"Front Biosci"},{"issue":"4","key":"1584_CR22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","volume":"59","author":"HI Pass","year":"1995","unstructured":"Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ (1995) Characteristics of nine newly derived mesothelioma cell lines. Ann Thorac Surg 59(4):835\u2013844","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"1584_CR23","first-page":"3199","volume":"47","author":"FR Reale","year":"1987","unstructured":"Reale FR, Griffin TW, Compton JM, Graham S, Townes PL, Bogden A (1987) Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model. Cancer Res 47(12):3199\u20133205","journal-title":"Cancer Res"},{"key":"1584_CR24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1476-4598-9-314","volume":"9","author":"A Shukla","year":"2010","unstructured":"Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT (2010) Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer 9:314. doi: 10.1186\/1476-4598-9-314","journal-title":"Mol Cancer"},{"issue":"1","key":"1584_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2006.08.010","volume":"38","author":"NG Ordonez","year":"2007","unstructured":"Ordonez NG (2007) What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 38(1):1\u201316","journal-title":"Hum Pathol"},{"issue":"3","key":"1584_CR26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/path.2107","volume":"211","author":"KF Becker","year":"2007","unstructured":"Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nahrig J, Becker I, Hofler H (2007) Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol 211(3):370\u2013378","journal-title":"J Pathol"},{"issue":"6","key":"1584_CR27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5858\/2009-0676-OA.1","volume":"135","author":"H Kothmaier","year":"2011","unstructured":"Kothmaier H, Rohrer D, Stacher E, Quehenberger F, Becker KF, Popper HH (2011) Comparison of formalin-free tissue fixatives: a proteomic study testing their application for routine pathology and research. Arch Pathol Lab Med 135(6):744\u2013752","journal-title":"Arch Pathol Lab Med"},{"issue":"395","key":"1584_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/01621459.1986.10478341","volume":"81","author":"J Shaffer","year":"1986","unstructured":"Shaffer J (1986) Modified sequentially rejective multiple test procudures. J Am Stat Assoc 81(395):826\u2013831","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"1584_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12254-011-0241-z","volume":"4","author":"L Arzt","year":"2011","unstructured":"Arzt L, Kothmaier H, Quehenberger F, Halbwedl I, Popper HH (2011) STAT signalling in malignant mesothelioma: is there a regulatory effect of microRNAs? Mag Eur Med Oncol 4(1):38\u201342","journal-title":"Mag Eur Med Oncol"},{"issue":"8","key":"1584_CR30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cellsig.2005.06.016","volume":"18","author":"J Ma","year":"2006","unstructured":"Ma J, Cao X (2006) Regulation of Stat3 nuclear import by importin alpha5 and importin alpha7 via two different functional sequence elements. Cell Signal 18(8):1117\u20131126","journal-title":"Cell Signal"},{"issue":"27","key":"1584_CR31","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.0802130105","volume":"105","author":"N Wenta","year":"2008","unstructured":"Wenta N, Strauss H, Meyer S, Vinkemeier U (2008) Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci USA 105(27):9238\u20139243","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1584_CR32","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/emboj\/21.7.1754","volume":"21","author":"KM McBride","year":"2002","unstructured":"McBride KM, Banninger G, McDonald C, Reich NC (2002) Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. Embo J 21(7):1754\u20131763","journal-title":"Embo J"},{"issue":"5343","key":"1584_CR33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.278.5343.1630","volume":"278","author":"A Kumar","year":"1997","unstructured":"Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR (1997) Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278(5343):1630\u20131632","journal-title":"Science"},{"issue":"16","key":"1584_CR34","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","volume":"14","author":"AC Mita","year":"2008","unstructured":"Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008) Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14(16):5000\u20135005. doi: 10.1158\/1078-0432.ccr-08-0746","journal-title":"Clin Cancer Res"},{"issue":"15","key":"1584_CR35","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2174\/092986710790979935","volume":"17","author":"RK Kanwar","year":"2010","unstructured":"Kanwar RK, Cheung CH, Chang JY, Kanwar JR (2010) Recent advances in anti-survivin treatments for cancer. Curr Med Chem 17(15):1509\u20131515","journal-title":"Curr Med Chem"},{"issue":"11","key":"1584_CR36","doi-asserted-by":"crossref","first-page":"e14076","DOI":"10.1371\/journal.pone.0014076","volume":"5","author":"M Zimmerman","year":"2010","unstructured":"Zimmerman M, Yang D, Hu X, Liu F, Singh N, Browning D, Ganapathy V, Chandler P, Choubey D, Abrams SI, Liu K (2010) IFN-gamma upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells. PLoS One 5(11):e14076. doi: 10.1371\/journal.pone.0014076","journal-title":"PLoS One"},{"issue":"3","key":"1584_CR37","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr1680","volume":"9","author":"M Berishaj","year":"2007","unstructured":"Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, Bornmann W, Bromberg JF (2007) Stat3 is tyrosine-phosphorylated through the interleukin-6\/glycoprotein 130\/Janus kinase pathway in breast cancer. Breast Cancer Res 9(3):R32. doi: 10.1186\/bcr1680","journal-title":"Breast Cancer Res"},{"issue":"5","key":"1584_CR38","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1074\/jbc.M112.386573","volume":"288","author":"DA Braun","year":"2013","unstructured":"Braun DA, Fribourg M, Sealfon SC (2013) Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J Biol Chem 288(5):2986\u20132993. doi: 10.1074\/jbc.M112.386573","journal-title":"J Biol Chem"},{"key":"1584_CR39","doi-asserted-by":"crossref","unstructured":"Russell MA, Cooper AC, Dhayal S, Morgan NG (2013) Differential effects of interleukin-13 and interleukin-6 on Jak\/STAT signaling and cell viability in pancreatic beta-cells. Islets 5 (2)","DOI":"10.4161\/isl.24249"},{"key":"1584_CR40","author":"X Yang","year":"2013","unstructured":"Yang X, Liang L, Zhang XF, Jia HL, Qin Y, Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, Wei JW, Zhou HJ, Ren N, Ye QH, Dong QZ, Qin LX (2013) MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting IL-6-Stat3 pathway. Hepatology. doi: 10.1002\/hep.26305","journal-title":"Hepatology"},{"issue":"9","key":"1584_CR41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI0215617","volume":"109","author":"J Bromberg","year":"2002","unstructured":"Bromberg J (2002) Stat proteins and oncogenesis. J Clin Invest 109(9):1139\u20131142. doi: 10.1172\/jci15617","journal-title":"J Clin Invest"},{"issue":"4","key":"1584_CR42","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2002-07-2130","volume":"101","author":"Y Aoki","year":"2003","unstructured":"Aoki Y, Feldman GM, Tosato G (2003) Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101(4):1535\u20131542. doi: 10.1182\/blood-2002-07-2130","journal-title":"Blood"},{"issue":"40","key":"1584_CR43","doi-asserted-by":"crossref","first-page":"41679","DOI":"10.1074\/jbc.M406413200","volume":"279","author":"Y Qing","year":"2004","unstructured":"Qing Y, Stark GR (2004) Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279(40):41679\u201341685. doi: 10.1074\/jbc.M406413200","journal-title":"J Biol Chem"},{"issue":"28","key":"1584_CR44","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T (2007) JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282(28):20059\u201320063. doi: 10.1074\/jbc.R700016200","journal-title":"J Biol Chem"},{"issue":"10","key":"1584_CR45","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.97.10.5267","volume":"97","author":"J Liao","year":"2000","unstructured":"Liao J, Fu Y, Shuai K (2000) Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction. Proc Natl Acad Sci USA 97(10):5267\u20135272","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1584_CR46","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood-2002-12-3816","volume":"102","author":"D Ungureanu","year":"2003","unstructured":"Ungureanu D, Vanhatupa S, Kotaja N, Yang J, Aittomaki S, Janne OA, Palvimo JJ, Silvennoinen O (2003) PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102(9):3311\u20133313. doi: 10.1182\/blood-2002-12-3816","journal-title":"Blood"},{"issue":"6","key":"1584_CR47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.molcel.2009.07.021","volume":"35","author":"JH Lee","year":"2009","unstructured":"Lee JH, Park SM, Kim OS, Lee CS, Woo JH, Park SJ, Joe EH, Jou I (2009) Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol Cell 35(6):806\u2013817. doi: 10.1016\/j.molcel.2009.07.021","journal-title":"Mol Cell"},{"issue":"9","key":"1584_CR48","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1096\/fj.08-106831","volume":"22","author":"S Madonna","year":"2008","unstructured":"Madonna S, Scarponi C, De Pita O, Albanesi C (2008) Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1\/2 activation. FASEB J 22(9):3287\u20133297","journal-title":"FASEB J"},{"key":"1584_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-10-142","volume":"10","author":"GB Lesinski","year":"2010","unstructured":"Lesinski GB, Zimmerer JM, Kreiner M, Trefry J, Bill MA, Young GS, Becknell B, Carson WE 3rd (2010) Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer 10:142. doi: 10.1186\/1471-2407-10-142","journal-title":"BMC Cancer"},{"issue":"2","key":"1584_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/156800906776056491","volume":"6","author":"L Klampfer","year":"2006","unstructured":"Klampfer L (2006) Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets 6(2):107\u2013121","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"1584_CR51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.27611","volume":"132","author":"K Iwahori","year":"2013","unstructured":"Iwahori K, Serada S, Fujimoto M, Ripley B, Nomura S, Mizuguchi H, Shimada K, Takahashi T, Kawase I, Kishimoto T, Naka T (2013) SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma. Int J Cancer 132(2):459\u2013471. doi: 10.1002\/ijc.27611","journal-title":"Int J Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1584-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-014-1584-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-014-1584-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:49:20Z","timestamp":1649008160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-014-1584-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1007\/s00428-014-1584-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,17]]}}}